SECTOR OVERVIEW
📁
Health Technology
MOST VOLATILE
Accuracy (30D)
0%
42 recent eventsGap PnL (Fix)
0
$100 baseGap Balance
0
CompoundPost PnL (Fix)
0
$100 basePost Bal
0
Compound📈 Group Equity Curve
Cumulative performance based on a $100 fixed bet per earnings event.
🧠 AI Sentiment
🔒
Locked
⏳ Next Opportunities in this Group
| Asset | Date | Timing | Action |
|---|---|---|---|
![]() $MLAB Mesa Laboratories Inc | May 27, 2026 | After Close | PREVIEW → |
![]() $NYKD.OL Nykode Therapeutics ASA | May 27, 2026 | After Close | PREVIEW → |
![]() $IMVT Immunovant Inc | May 28, 2026 | After Close | PREVIEW → |
![]() $RGC Regencell Bioscience Holdings Ltd | Jun 02, 2026 | After Close | PREVIEW → |
![]() $2M6.DE Medtronic PLC | Jun 03, 2026 | After Close | PREVIEW → |
🏢 Group Constituents List
| Asset ↕ | Events ↕ | Win Rate 🔒 | Net PnL 🔒 |
|---|---|---|---|
GSK
GlaxoSmithKline plc ADR
|
11 |
88%
🔒
|
+$5000
🔒
|
GLPG
Galapagos NV
|
11 |
88%
🔒
|
+$5000
🔒
|
OVID
Ovid Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ALDX
Aldeyra Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
EDIT
Editas Medicine Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
MGNX
MacroGenics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
NSPR
InspireMD Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ORIC
ORIC Pharmaceuticals Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
DTIL
Precision BioSciences Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
LYEL
Lyell Immunopharma Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ARAY
Accuray Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
DERM
Journey Medical Corp
|
11 |
88%
🔒
|
+$5000
🔒
|
DNLI
Denali Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
FULC
Fulcrum Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
PRAX
Praxis Precision Medicine
|
11 |
88%
🔒
|
+$5000
🔒
|
LPCN
Lipocine Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
CDNA
CareDx Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
AURA
Aura Biosciences Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
AZN
AstraZeneca PLC ADR
|
11 |
88%
🔒
|
+$5000
🔒
|
CABA
Cabaletta Bio Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
CODX
Co-Diagnostics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ZEAL.CO
Zealand Pharma A/S
|
11 |
88%
🔒
|
+$5000
🔒
|
ELVN
Enliven Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
FDMT
4D Molecular Therapeutics
|
11 |
88%
🔒
|
+$5000
🔒
|
HUMA
Humacyte Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
PGEN
Precigen Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
PHAT
Phathom Pharmaceuticals I
|
11 |
88%
🔒
|
+$5000
🔒
|
RCEL
AVITA Medical Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ABEO
Abeona Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
DSGN
Design Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ARCT
Arcturus Therapeutics Hol
|
11 |
88%
🔒
|
+$5000
🔒
|
BHVN
Biohaven Ltd
|
11 |
88%
🔒
|
+$5000
🔒
|
CRMD
CorMedix Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
HOWL
Werewolf Therapeutics Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
PDSB
PDS Biotechnology Corpora
|
11 |
88%
🔒
|
+$5000
🔒
|
TSHA
Taysha Gene Therapies Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
KOD
Kodiak Sciences Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
EBS
Emergent BioSolutions Inc
|
11 |
88%
🔒
|
+$5000
🔒
|
ALLO
Allogene Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
KYMR
Kymera Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
AUTL
Autolus Therapeu
|
10 |
88%
🔒
|
+$5000
🔒
|
NUVB
Nuvation Bio Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
KIDS
OrthoPediatrics Corp
|
10 |
88%
🔒
|
+$5000
🔒
|
KROS
Keros Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
NERV
Minerva Neurosciences Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
PLX
Protalix Biotherapeutics
|
10 |
88%
🔒
|
+$5000
🔒
|
ZNTL
Zentalis Pharmaceuticals
|
10 |
88%
🔒
|
+$5000
🔒
|
RGNX
REGENXBIO Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
TNGX
Tango Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
CMPX
Compass Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
ETON
Eton Pharmaceuticals Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
IMRX
Immuneering Corporation
|
10 |
88%
🔒
|
+$5000
🔒
|
INKT
Mink Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
OMER
Omeros Corp
|
10 |
88%
🔒
|
+$5000
🔒
|
PMVP
Pmv Pharmaceuticals Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
SPRY
ARS Pharmaceuticals Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
MIST
Milestone Pharmaceuticals
|
10 |
88%
🔒
|
+$5000
🔒
|
SCYX
Scynexis Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
CNTA
Centessa Pharmaceuticals
|
10 |
88%
🔒
|
+$5000
🔒
|
MGTX
MeiraGTx Holdings plc
|
10 |
88%
🔒
|
+$5000
🔒
|
PROK
ProKidney Corp
|
10 |
88%
🔒
|
+$5000
🔒
|
BTAI
Bioxcel Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
SAN.PA
Sanofi
|
10 |
88%
🔒
|
+$5000
🔒
|
ARDX
Ardelyx Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
PRCT
PROCEPT BioRobotics Corpo
|
10 |
88%
🔒
|
+$5000
🔒
|
ARGX
Argenx SE-ADR
|
10 |
88%
🔒
|
+$5000
🔒
|
DNTH
Dianthus Therapeutics Inc
|
10 |
88%
🔒
|
+$5000
🔒
|
HLN
Haleon PLC-ADR
|
9 |
88%
🔒
|
+$5000
🔒
|
BCAB
Bioatla Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
LQDA
Liquidia Corporation
|
9 |
88%
🔒
|
+$5000
🔒
|
MRVI
Maravai LifeSciences Hold
|
9 |
88%
🔒
|
+$5000
🔒
|
IDYA
IDEAYA Biosciences Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
SLDB
Solid Biosciences Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
GHRS
GH Research PLC
|
9 |
88%
🔒
|
+$5000
🔒
|
GOSS
Gossamer Bio Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
MRK.DE
MERCK KGAA
|
9 |
88%
🔒
|
+$5000
🔒
|
KALA
Kala Bio Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
MBRX
Moleculin Biotech Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
GNLX
Genelux Corporation
|
9 |
88%
🔒
|
+$5000
🔒
|
RVPH
Reviva Pharmaceuticals Ho
|
9 |
88%
🔒
|
+$5000
🔒
|
SGMO
Sangamo Therapeutics Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
NXTC
NextCure Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
MLYS
Mineralys Therapeutics In
|
9 |
88%
🔒
|
+$5000
🔒
|
ATRA
Atara Biotherapeutics Inc
|
9 |
88%
🔒
|
+$5000
🔒
|
BCYC
Bicycle Therapeutics plc
|
8 |
88%
🔒
|
+$5000
🔒
|
PHVS
Pharvaris NV
|
8 |
88%
🔒
|
+$5000
🔒
|
LAB
Standard Biotool
|
8 |
88%
🔒
|
+$5000
🔒
|
LYRA
Lyra Therapeutics Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
FLNA
Filana Therapeutics Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
NUWE
Nuwellis Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
IVVD
Invivyd Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
NKTX
Nkarta Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
CYPH
Cypherpunk Technologies I
|
8 |
88%
🔒
|
+$5000
🔒
|
JAGX
Jaguar Health Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
OTLK
Outlook Therapeutics Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
KRRO
Korro Bio Inc
|
8 |
88%
🔒
|
+$5000
🔒
|
MTNB
Matinas BioPharma Holding
|
7 |
88%
🔒
|
+$5000
🔒
|
GRCE
Grace Therapeutics Inc
|
7 |
88%
🔒
|
+$5000
🔒
|
PRLD
Prelude Therapeutics Inc
|
7 |
88%
🔒
|
+$5000
🔒
|
LGVN
Longeveron Inc-A
|
6 |
88%
🔒
|
+$5000
🔒
|
NBY
NovaBay Pharmaceuticals I
|
6 |
88%
🔒
|
+$5000
🔒
|
KALV
KalVista Pharmaceuticals
|
6 |
88%
🔒
|
+$5000
🔒
|
GRAL
Grail Inc
|
6 |
88%
🔒
|
+$5000
🔒
|
OKUR
OnKure Therapeutics Inc
|
6 |
88%
🔒
|
+$5000
🔒
|
DMRA
Damora Therapeutics Inc
|
5 |
88%
🔒
|
+$5000
🔒
|
XXII
22nd Century Group Inc.
|
5 |
88%
🔒
|
+$5000
🔒
|
CVM
Cel-Sci Corp
|
5 |
88%
🔒
|
+$5000
🔒
|
PLSE
Pulse Biosciences Inc
|
5 |
88%
🔒
|
+$5000
🔒
|
NBP
NovaBridge Biosciences
|
5 |
88%
🔒
|
+$5000
🔒
|
ASPI
ASP Isotopes Inc
|
5 |
88%
🔒
|
+$5000
🔒
|
GYRE
Gyre Therapeutics Inc
|
5 |
88%
🔒
|
+$5000
🔒
|
PVLA
Palvella Therapeutics Inc
|
5 |
88%
🔒
|
+$5000
🔒
|
GNPX
Genprex Inc
|
4 |
88%
🔒
|
+$5000
🔒
|
6185.HK
CanSino Biologics Inc
|
4 |
88%
🔒
|
+$5000
🔒
|
MAZE
Maze Therapeutics Inc
|
4 |
88%
🔒
|
+$5000
🔒
|
UPXI
Upexi Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
GRF.MC
Grifols SA
|
3 |
88%
🔒
|
+$5000
🔒
|
KLRS
Kalaris Therapeutics Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
JBIO
Jade Biosciences Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
CAI
Caris Life Sciences Inc
|
3 |
88%
🔒
|
+$5000
🔒
|
GRFS
Grifols SA
|
2 |
88%
🔒
|
+$5000
🔒
|
FIE.DE
Fielmann AG
|
2 |
88%
🔒
|
+$5000
🔒
|
AZT.OL
Arcticzymes Technologies
|
2 |
88%
🔒
|
+$5000
🔒
|
EVLO
Evelo Biosciences Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
LIFE.OL
Lifecare ASA
|
1 |
88%
🔒
|
+$5000
🔒
|
EVFM
Evofem Biosciences Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
1SXP.DE
SCHOTT Pharma AG & Co Kga
|
1 |
88%
🔒
|
+$5000
🔒
|
ZOMDF
Zomedica Corp
|
1 |
88%
🔒
|
+$5000
🔒
|
MEDI.OL
Medistim ASA
|
1 |
88%
🔒
|
+$5000
🔒
|
FRMM
Forum Markets Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
AVXL
Anavex Life Sciences Corp
|
1 |
88%
🔒
|
+$5000
🔒
|
CLLS
Cellectis SA-ADR
|
1 |
88%
🔒
|
+$5000
🔒
|
ALCLS.PA
Cellectis SA
|
1 |
88%
🔒
|
+$5000
🔒
|
BLTE
Belite Bio Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
REPL
Replimune Group Inc
|
1 |
88%
🔒
|
+$5000
🔒
|
NNOX
Nano-X Imaging Ltd.
|
1 |
88%
🔒
|
+$5000
🔒
|
🔒 The historical Win Rate and precise Net PnL of each constituent are strictly reserved for PRO Members.
Unlock Premium Metrics




